Dr. Raquel Peyraube, MD

Dr. Raquel Peyraube, MD

Dr. Raquel Peyraube, MD

Drug Policy, Endocannabinology, Medical Education | Uruguay

She is Medical Doctor graduated at the Medicine School of the Universidad de la República and specialist on Drug field and Endocannabinology. She is the founder and current president of the Uruguayan Society of Endocannabinology (SUEN). Throughout her career she was involved in training, prevention, treatment and drug related harm reduction, including innovative theoretical and methodological developments with an emphasis on ethical issues, which earned her regional and international recognition. She has been advocating drug policy reform in several countries.

In her country, she has been ad hoc advisor of the National Board on Drugs (SND) in the reform of the public drug policy and the Institute of Regulation and Control of Cannabis (IRCCA) of Uruguay, and actively participated in the elaboration of the law that regulates cannabis for all purposes.

She is a member of the Executive Committee of International Association for Cannabinoid Medicines (IACM) and member of the International Cannabinoids Research Society.

She is the designer and academic coordinator of the 1st International Medical Cannabis Course for physicians and nurses endorsed by IACM and protocoled it to be implemented in different contexts. Also, she is scientific advisor of foundations and companies working in medical cannabis interested in developing clinical trials and public education on this field.

On May 2017 she has founded the Uruguayan Society of Endocannabinology and became its founder president. Currently she is mainly dedicated to cannabis medicine practice, the development of protocols for clinical trials for research, medical cannabis education for health professionals, and consulting on Drug Policy Reform, particularly cannabis legalization in different countries.

Cannabis and Cannabinoids in the Treatment of Osteoarticular Chronic Pain.
Through the presentation of a clinical case of chronic pain of osteoarticular cause, that will show the possibilities of treatment for these situations, the evolution pointing out the benefits obtained and the adverse effects, as well as the impact on other pathologies and the Patient’s life.
She will also discuss the known and potential mechanisms of action that underpin the use of cannabis and cannabinoids in these pathologies, interactions with other drugs and the precautions to be observed.

Activities in EXPOCANNABIS URUGUAY 2017:
She coordinates and attends the Office of Orientation in Medicinal Cannabis (link a pagina del consultorio) and is the responsible of the three workshops that are offered in the Room